Promiseb Topical Cream for Cradle Cap

A Double Blind, Placebo-Controlled, Pilot Study to Estimate the Efficacy and Tolerability of Twice Daily Promiseb Topical Cream in Pediatric Subjects With Cradle Cap (Seborrheic Dermatitis)

The purpose of this study is to evaluate the efficacy and safety of Promiseb Topical Cream in cradle cap.

Inclusion Criteria:

• Clinical diagnosis of cradle cap
• Must be at least 30 days old
• Must be in good health as determined by investigator
• Naive to prior cradle cap therapy (may have used mineral, olive oils)

Exclusion Criteria:

• Known food, topical product or medicinal allergies.
• Prior use of corticosteroids, antifungals or keratolytics for Cradle Cap
• Weighing less than 7 lbs